Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Zhixiang Shen"'
Publikováno v:
Cancer Communications, Vol 38, Iss 1, Pp 1-9 (2018)
Abstract Background Patients with relapsed/refractory B-cell lymphomas have limited treatment options. GERSHWIN is an open-label, single-arm, phase Ib study of obinutuzumab monotherapy in Chinese patients with histologically documented CD20+ relapsed
Externí odkaz:
https://doaj.org/article/897d7fb5439c4f71ba7b9c6909dc7819